dr. carbone on acquired resistance to osimertinib in nsclc
Published 4 years ago • 586 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:04
acquired resistance to osimertinib in t790m-positive nsclc
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:16
dr. goldberg on options after developing resistance to osimertinib for nsclc
-
0:34
candidate mechanisms of acquired resistance to first-line osimertinib in egfr-mutated... | rtcl.tv
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
1:43
dr. padda on overcoming resistance to osimertinib in egfr nsclc
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
0:38
analysis of acquired resistance mechanisms to osimertinib in patients with egfr-mutat... | rtcl.tv
-
2:23
dr. zhu on primary resistance to osimertinib in egfr-mutant nsclc
-
0:42
can we predict osimertinib resistance?
-
1:04
dr. carbone on the importance of personalizing immunotherapy in nsclc
-
11:23
2020 ttf egfr breakout piotrowska part 1 - current options upon acquired resistance to osimertinib
-
2:02
understanding egfr resistance in patients with met-amplified nsclc
-
11:53
insight 2: a phase ii study of tepotinib plus osimertinib in met-amplified nsclc
-
1:31
dr. gold on the future of osimertinib in lung cancer
-
5:29
osimertinib for the t790m resistance mutation